Symbol Name ID |
Slc25a13
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 MGI:1354721 |
Darker colors indicate more annotations |
Human Phenotypes | Elevated plasma citrulline |
Hypertyrosinemia |
Hyperlysinemia |
Hypermethioninemia |
Hyperthreoninemia |
Hyperargininemia |
Hyperbilirubinemia |
Conjugated hyperbilirubinemia |
Increased serum bile acid concentration |
Decreased HDL cholesterol concentration |
Hypercholesterolemia |
Hypertriglyceridemia |
Hyperammonemia |
Elevated circulating alanine aminotransferase concentration |
Elevated circulating aspartate aminotransferase concentration |
Elevated gamma-glutamyltransferase level |
Elevated circulating alkaline phosphatase concentration |
Cerebral edema |
Hepatic steatosis |
Macrovesicular hepatic steatosis |
Microvesicular hepatic steatosis |
Argininosuccinic aciduria |
Disease(s) Associated with SLC25A13 | ||||||||||||||||||||||
adult-onset type II citrullinemia | ||||||||||||||||||||||
neonatal-onset type II citrullinemia |
Mouse Phenotypes | abnormal amino acid level |
hypoglycemia |
decreased circulating insulin level |
abnormal gluconeogenesis |
increased liver triglyceride level |
abnormal urine homeostasis |
|
Availability | Mouse Genotype | ||||||
Slc25a13tm1Lct/Slc25a13tm1Lct | |||||||
Slc25a13tm1Lct/Slc25a13+ |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|